Me is not doing well. Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month ...

With all seven independent directors resigning from 23andMe millions of customers are questioning how the company plans to ...

Usually, introductory meetings with startup executives are perfunctory and fade to irrelevance within an hour. But I still ...

September 30, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of directors and the co-founder ...

ME INVESTIGATION UPDATE: 23andMe Holding Co. Shareholders are Encouraged to Contact BFA Law about the Potential Lawsuit against the Company ...

EXCLUSIVE: A crucial oversight led to disaster for father-of-two Sean Clifford, who can no longer dress himself, speak ...

If you are a holder of 23andMe, you are encouraged to submit your information at: On July 29, 2024, CEO Wojcicki submitted a non-binding proposal to 23andMe to acquire all shares of 23andMe that were ...

A man in New Jersey was left partially paralysed after a healthcare startup failed to diagnose a blockage in his brain. He is ...

Nucleus Genomics, a relatively obscure genomics company, has announced its interest in acquiring 23andMe, following a ...

23andMe's entire board of directors resigned from the company over cofounder and CEO Anne Wojcicki's ongoing plans to take it private. In a letter to Wojcicki on Tuesday — which was also posted ...

In April, a Securities and Exchange Commission filing revealed that Wojcicki planned to take the company private. 23andMe’s stock price had fallen below $1 per share at the time, down from its $10 ...